PBGH Announcements
For Media Inquiries:
Lisa Zamosky
(917) 751-0232
lzamosky@pbgh.org
EmployersRx Statement for Drug Cost Provisions in the Build Back Better Act
The Employers’s Prescription for Affordable Drugs (EmployersRx) coalition applauds the work of congressional leaders to reach agreement regarding prescription drug provisions to be included in the Build Back Better Act.
National Employer Group Praises Drug Deal Announced Today
The Purchaser Business Group on Health (PBGH) commends congressional negotiators who struck a landmark deal to reform the prescription drug market.
Statement on the New Budget Reconciliation Framework
The Purchaser Business Group on Health is profoundly disappointed that the budget reconciliation framework announced today by President Biden omits any policies to deal with unaffordable prescription drugs.
PBGH Strongly Supports the No Surprises Act Interim Final Rule: A Big Win for Consumers and Employers
On Sept. 30, the Departments of Health and Human Services, Labor and Treasury, released an interim final rule (IFR) implementing the No Surprises Act.
Quality Improvement Project to Modernize Primary Care Launched
Covered California, the California Public Employees’ Retirement System (CalPERS) and the Purchaser Business Group on Health (PBGH) are partnering to launch a pilot program to promote improvement in primary care which will benefit all Californians.
Patients and Employers Agree: Congress Must Allow Medicare to Negotiate Lower Drug Prices for Americans
Patients and employers urge the House Ways and Means and Energy and Commerce Committees to move forward with H.R. 3, a bill that will empower Medicare to negotiate lower drug prices on behalf of Americans.
EmployersRx: Congress Must Reduce Drug Costs for Everyone
Congressional leaders are currently drafting legislation that would allow the federal government to negotiate the price of high-cost drugs and those newly entering the market.
Final Approval Granted for the Sutter Health Settlement
The settlement agreement achieved in the Sutter Health case, along with the injunctive relief, will have a significant and beneficial economic impact.
PBGH Statement on President Biden’s Remarks on Lowering Drug Costs
Addressing health care costs, and in particular the cost of prescription drugs, is an economic issue. Earnings siphoned off by health care costs limit job creation and wage growth, divert investment and cripple competitiveness and innovation.
PBGH Statement in Response to CMS Raising Penalties for Hospitals Failing to Make Prices Public
We are very pleased that the Biden administration is signaling its intention to aggressively implement the previous administration’s hospital price transparency rule.
